ICON Partners with Anthropic to Transform Clinical Trials with AI
DUBLIN, Ireland, July 28, 2026 DUBLIN, Ireland, July 28, 2026 – ICON plc announced a multi-year strategic collaboration with...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
DUBLIN, Ireland, July 28, 2026 DUBLIN, Ireland, July 28, 2026 – ICON plc announced a multi-year strategic collaboration with...
MENLO PARK, Calif., June 29, 2026 BillionToOne has announced the publication of a peer-reviewed clinical study demonstrating that its...
NEW YORK, June 30, 2026 Inductive Bio, Inc. has announced its integration into Anthropic’s Connector Ecosystem for Life Sciences,...
